1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas 77056 713.963.5860 www.claytonbiotech.com Overview of Clayton Biotechnologies,

Slides:



Advertisements
Similar presentations
David M. Pollock Medical College of Georgia Discovery-Academia.
Advertisements

Personalized Medicine in California Kathryn Lowell, Deputy Secretary for Life Sciences and Health Systems February, 2009.
Health, Disease and Survival The Essex Biomedical Sciences Institute Essex Biomedical Sciences Institute Dr Beverley Wilkinson Department of Biological.
2nd Panel, Best Practices: “ IPR in Successful University-Industry Collaborations” Dr. Tamar Raz, CEO Hadasit, the Technology Transfer Company of Hadassah.
1 LeTourneau University Tim Ochran, MS, DABR, Associate Professor of Radiation Oncology, UTHSCT January 26, 2011.
BY THE NUMBERS TEXAS IN FY 2012 $261 Million: NSF funds awarded 8 th : National ranking in NSF funds 83: NSF-funded institutions 1,180: NSF grants awarded.
Alexandra Richardson, PhD, CLP April Clayton Biotechnologies, Inc. is a for-profit company which facilitates the commercialization of medical.
Building the Biotechnology Sector in Houston Introduction Houston Biotechnology Atmosphere Why so few companies? Possible solutions.
Texas-United Kingdom Collaborative Saint Petersburg 2011 Dr. James Abbey International Strategic Collaborations Advisor Swansea University.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Cancer Center March 30, 2015 Houston Methodist. Vision Houston Methodist will be a nationally recognized cancer center, delivering high quality patient-centered.
1 Welcome To Rural Sociology 2225 “Science, Technology and Society” Mary Grigsby Associate Professor of Rural Sociology Division of Applied Social Sciences.
Introduction to Grants Resources in the Health Sciences by Min-Lin Fang, MLIS Education and Information Consultant for Nursing and Social & Behavioral.
Protein Therapeutics: a summary and pharmacological classification
Therapeutic Peptides for Cardiovascular Disease and Cancer Cam Patterson, MD, MBA, FACC, FAHA Ernest and Hazel Craige Distinguished Professor of Cardiovascular.
Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.
HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.
The Alfred E. Mann Institute for Biomedical Engineering An Experiment in Technology Transfer Gerald E. Loeb, M.D. Director of the Medical Device Development.
Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.
1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
Jeans for Genes Day High School Presentation. Section: one What is Jeans for Genes Day?
Proposal for a European Faculty of Regenerative Medicine ScanBalt Campus Knowledge centers.
Experience.  Lecture “ Alive cells –drugs - from medical, pharmaceutical and ethical aspects  Stem cells became the serious of scientific research,
National Yang-Ming University Office of Research and Development 2010 Aug Introduction.
Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.
Pharmacologist & Toxicologist CTE Introduction. What is a Pharmacologist? Develop new drugs to cure, treat, and prevent disease. Develop new drugs to.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Review of Technology Transfer at The University of Texas System Margaret Sampson Partner, Vinson & Elkins LLP U. T. System Board of Regents’ Meeting Technology.
Synapse and Catapult– New NIH OTT Technology Transfer Tools Ajoy K. Prabhu, M.S., M.B.A. Group Leader, Marketing Office of Technology Transfer National.
Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.
Driving Innovation to Market. Partnering with the Office of Intellectual Property and Industry Sponsored Research December 10, 2013 Tara A. Kamin, Esq.
A symposium presented by the IUPS Ethics Committee 37 th Congress IUPS Birmingham UK July 2013.
National Yang-Ming University Office of Research and Development 2009 May Introduction.
1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,
Overview Industry Overview Impacted Industries Science Business Issues Examples Where do you fit? Getting Involved Websites Other Resources.
John M. Simpson Stem Cell Project Director Foundation for Taxpayer and Consumer Rights Tel: URL:
Unit 11 Power Notes – Part 1 Science, Technology and Medicine in the mid to late 20 th century (Chapter 24-26)
03/10/2008 Terese Rakow, PhD. Postdoctoral Career Development Course March 10, 2008.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
Lighting the Next-Generation Network Across Texas an update on the project _________________________ ___________ Jim Williams.
1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,
About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events.
Biotechnology and Schools: What’s the Connection?.
Consortium for Interdisciplinary Studies on Science for Aging.
 How does DNA help us in medicine? QOTD. Mr.Dunnum DNA TECHNOLOGY.
Medical Technology Essential Questions:
Commercializing Inventions at Baylor Research, Technology Inventions Baylor Licensing Group BCM Technologies, Inc.
Allied health professionals make up 60 percent of the total health workforce. They work in health care teams to make the healthcare system function by.
OMICS international Contact us at: OMICS International through its Open Access Initiative is committed to make genuine and.
OMICS international Contact us at: OMICS International through its Open Access Initiative is committed to make genuine and.
Happy 1 st birthday! (Launched 28 Oct 2011)
 HCC STEM INTERNSHIP Roa Sadat. Overview  Benefits of STEM  How I was introduced to Dr. Tineke Berends and the program  My internship experience 
BioMedical Cluster New opportunities for innovators and investors with Bio-Medical Cluster of Skolkovo Foundation Innovation in Medical Technologies Conference,
Vesalius Ventures “VC’s View of the Future of Technology” Technology Showcase Houston Technology Center Bernard A. Harris, Jr. President & CEO.
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
Alexandra Richardson, PhD, CLP July Clayton Biotechnologies, Inc. is a for-profit company which facilitates the commercialization of medical discoveries.
Technological excellence
Coalition for National Science Funding (CNSF) 
Equipment Maintenance Direct $pend Opportunity
Companies Researching Cancer Treatments By: Amanda Garcia
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
Science and Technology
From Bench to Clinical Applications: Money Talks
Non For Profit Model for Rare Disease Therapy Development
Pediatric Preclinical Testing Consortium
Immunotherapeutics 18th Annual Research Retreat
Technological excellence
Review of Technology Transfer at The University of Texas System
Presentation transcript:

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies, Inc.

2 Clayton Biotechnologies, Inc. is a for-profit company which facilitates the commercialization of medical discoveries made by the Clayton Foundation for Research and its supporting entities. The Clayton Foundation for Research is a nonprofit medical research organization in Houston, Texas established in 1933 by Benjamin Clayton. The mission of the Foundation is two-fold: To transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products. To conduct medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind

3 We conduct and fund medical research programs at leading universities, hospitals and academic institutions ■ Baylor College of Medicine ■ Baylor College of Medicine Texas Children's Cancer Center ■ North Carolina State University ■ Oregon Health and Science University ■ Salk Institute for Biological Studies ■ The University of Texas at Austin ■ The University of Texas Health Science Center at Houston ■ The University of Texas M.D. Anderson Cancer Center ■ The University of Texas Medical Branch at Galveston ■ University of California, San Diego ■ University of Geneva

4 Some of our start-up companies Depotech, Inc.

5 Some of our Other Licensees

6 Products Brought to the Market Diagnostics Medical devices SCA6 diagnostic tests Complete Ataxia Evaluation Therapeutics EXPAREL™

7 FEATURED TECHNOLOGIES VEGF/rGEl – ADC targeting ocular neovascularization Drs. Rosenblum MD Anderson RTEF therapy for ocular neovascular disease Dr. Stout OHSU Conditional gene knock-down system using lentiviral-expressed RNAi Dr. Trono University of Geneva Prognostic Marker for Breast Cancer Treatment Dr. Keyomarsi, MD Anderson E-clonals: Fc engineering for agclysoated antibodies Dr. Georgiou University of Texas, Austin Pluripotent Stem Cells for Neurotoxicology Testing Dr. Krause University of Geneva Vaccines and Diagnostics for the Ehrlichioses Dr. McBride University of Texas Medical Branch CRFR1 antagnoists to treat tauopathies such as Alzheimer’s Disease Dr. Sawchenko Salk Institute Cripto antagonists for the treatement of cancer Dr. Vale Salk Institute Antibodies to Srpx2 and Olmfl3 targeting angiogenesis Dr. Imhof University of Geneva Avicins, new class of triterpnes to treat cancer – IND approved package Dr. Gutterman MD Anderson

8 Any questions? Please contact us! Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas